Skip to Content

Top Stories (STDW)

Syndicate content
Updated: 21 hours 10 min ago

The Next Five States That Could Legalize Marijuana [FEATURE]

Sun, 12/04/2016 - 16:48

This article as produced in collaboration with AlterNet and first appeared here.

Four states, including California, the nation's most populous, voted to legalize marijuana on November 8. That doubles the number of legal states to eight (plus the District of Columbia), and more than quadruples the number of people living in legal marijuana states, bringing the number to something around 64 million.

Every one of those states legalized marijuana through the initiative process, but we're not going to see any more initiatives on state ballots until 2018, and perhaps 2020. That means that if we are to make more progress on spreading marijuana legalization in the next couple of years, it's going to have to come at the state house instead of the ballot box.

[image:1 align:left caption:true]That's the same pattern we saw with medical marijuana. California led the way via the initiative process in 1996, with several other states following in 1998 and 2000 before Hawaii became the first state to okay medical marijuana via the state legislature.

The election of Donald Trump is causing great uncertainty about the future of legal marijuana, and will act as a drag on legislators until his stance is clarified. Just as governors hesitated to implement medical marijuana programs in the face of federal hostility a decade ago, legislators will hesitate to move toward legalization in the face of uncertainty, or worse, outright hostility from a Trump administration.

Still, efforts to legalize marijuana through the legislative process have been underway for several years in a handful of states and have already come close to passage in some of them. And now, especially in New England, the pressure of neighboring states having already embraced legalization is fueling legalization fervor. But it's not just New England. The marijuana legalization message is resonating across the land.

Getting a bill through a state legislature is a long, multi-stage process, with too many opportunities for getting derailed, from obstinate committee chairs to skeptical governors wielding the veto pen. Despite the obstacles, here are five states that could get it done before the 2018 mid-terms:

Connecticut

Connecticut already has medical marijuana and decriminalized possession in 2011 with the support of Gov. Dannel Malloy (D). Malloy had said that decriminalization was as far as he wanted to go, but he's hinting at changing his tune after marijuana's big victory on Election Day. "We might have to reexamine our legal position, our position of enforcement, based on what some surrounding states are doing," Malloy said three days later.

For veteran legislators such as state Reps. Juan Candelaria (D-New Haven) and Toni Walker (D-New Haven), Malloy's softening couldn't come soon enough. They've authored legalization bills in past sessions, but they haven't gotten much traction. Look for them to be back at it again next year, with the changed New England political landscape smoothing the road.

Maryland

Maryland approved medical marijuana in 2014 (although the long-delayed program has yet to see any actual dispensaries open) and decriminalization last year under then Democratic Gov. Martin O'Malley.

The bad news is that O'Malley is gone now, replaced by anti-marijuana Republican Gov. Larry Hogan. The good news is that the legislature has already demonstrated a willingness to override Hogan's vetoes when it comes to pot policy; it did that this year with a housekeeping bill that decriminalized the possession of paraphernalia (an oversight in the 2015 decriminalization bill).

Reform-minded legislators last year filed a legalization bill, the Marijuana Control and Revenue Act of 2015, in both houses, but they were stymied by unfriendly committee chairs. They're going to be back next year, backed by a carefully-built coalition of drug reform, social justice, and public health groups -- and with the support of a healthy majority of Marylanders, according to recent polls.

New Mexico

[image:2 align:right caption:true]Eyeing next door neighbor Colorado, New Mexico is another state ripe for marijuana legalization. Two polls this year had popular support for legalization at 61%, and Democrats have now won control of the state legislature. That means two different moves toward legalization could occur: Rep. Bill McCamley (D-Mesilla Park) has filed a legalization bill the last two years, and says he will do it again next year. "It's not an academic exercise anymore," he said. And Sen. Jerry Ortiz y Pino (D-Albuquerque) also says he will be introducing a constitutional amendment that would take the issue to a popular vote.

But like Maryland, legalizers face an anti-marijuana Republican governor in Susana Martinez. Either Martinez is going to have to have a pot epiphany or the legislature is going to have to have enough votes to override a probable veto.

Rhode Island

This may be the best prospect of the bunch. Medical marijuana is well-established in the state, decriminalization has been in effect for four years, and now, in the wake of the legalization victory in neighboring Massachusetts, Gov. Gina Raimundo (D) says she's ready to more seriously consider doing the same in Rhode Island, although she has concerns about public safety and how any legislation is drafted.

Democrats control both houses of the legislature, and both House Speaker Thomas Mattiello and Senate Majority Leader Dominick Ruggerio say they are ready to take up legalization bills. That would be a pleasant change: For the past six years, legalization bills have been filed, but never voted on.

Rhode Island's political leaders finally look ready to catch up to their constituents, 55% of whom supported legalization in a recent poll from Brown University and who smoke pot at the highest rate of any state, reporting a 16% past month use rate.

Vermont

Vermont very nearly became the first state to legalize weed through the legislative process this year. A legalization bill, S. 241, was supported by Gov. Peter Shumlin (D) and passed with strong support in the Senate, only to die in the House.

Now, a pair of key lawmakers said they are ready to try to get legalization through the legislature again. Sen. Dick Sears, chairman of the Senate Judiciary Committee, said legalization votes in Maine and Massachusetts are forcing the state's hand. "For me, that's a game-changer, that Massachusetts has voted to legalize," Sears said.

Sears' counterpart in the House, Judiciary Committee chairwoman Rep. Maxine Grad, is also ready to go, saying the Maine and Massachusetts votes will make lawmakers more amenable to moving forward.

There's just one problem: Shumlin is gone now, replaced by incoming Republican Gov. Phil Scott, who is not a big fan of government regulation, but is not a big fan of marijuana legalization, either. "I can appreciate the discussion around ending the prohibition of marijuana," he said, but had many, many concerns about this year's bill. Still, it's possible legislators will have heard those concerns and will come up with a bill that Scott can live with -- or a majority that can override a veto.

Categories: Latest News

Will Trump's Dead Alcoholic Brother Haunt His Drug Policy? [FEATURE]

Wed, 11/30/2016 - 22:46

This article was produced in collaboration with AlterNet and first appeared here.

As incoming president, Donald Trump will be, among other things, the man in charge of the nation's drug policy. Whether he takes a hand-on, direct approach to policy-making or whether he delegates decision-making authority on drug matters to subordinates -- think Attorney General Jeff Sessions and shudder -- the buck ultimately stops with Donald.

[image:1 align:left caption:true]What a Trump administration will do with states that have legalized marijuana is a huge burning question, but the drug policy horizon extends well beyond weed. The Obama administration has championed federal drug sentencing reform, and the president is now commuting the sentences of dozens of drug offenders each week as the clock ticks down on his tenure. Will Trump reverse course?

There's also a huge cry for drug treatment in response to increasing heroin and prescription opioid use. Will a Trump administration be sympathetic? And what about harm reduction -- needle exchanges, supervised consumption sites, and the like? Do such programs have a future under Trump?

The short answer is: Who knows? Trump is proving day by day that how he governs will not necessarily have much correlation with anything he said on the campaign trail. And, as with his approach to many policy areas, what he has said about drugs, both during the campaign and in his earlier life, sounds both spur-of-the-moment and self-contradictory.

But Trump is not just a rather unpredictable president-elect. He's also a person with his own personal and family history, and that history includes a close encounter with substance abuse that sheds some light on his attitudes towards drugs and may influence his drug policy decision-making.

Donald Trump's older brother, and his overbearing father's namesake, "Freddy, Jr." was a full-blown alcoholic by his mid-20s (and Donald's teens) and drank himself into an early grave at the age of 43 in 1981. Freddy wasn't ready to take over the family business and instead became a fun-loving airline pilot, but his descent into the bottle had a traumatic -- and lasting -- impact on his little brother.

[image:2 align:right caption:true]"I learned a lot from my brother Fred's death," Trump told Esquire in a 2004 interview. "He was a great-looking guy. He had the best personality. He had everything. But he had a problem with alcohol and cigarettes. He knew he had the problem, and it's a tough problem to have. He was ten years older than me, and he would always tell me not to drink or smoke. And to this day I've never had a cigarette. I've never had a glass of alcohol. I won't even drink a cup of coffee. I just stay away from those things because he had such a tremendous problem. Fred did me a great favor. It's one of the greatest favors anyone's ever done for me," he recalled.

Trump's experience with his brother turned him into a teetotaler, although he does swill Diet Coke instead. And he admits to one other "vice" in revealing terms. In a 2007 video, he said that hot women are his "alcoholism," especially "beautiful" teens.

"I never understood why people don't go after the alcohol companies like they did the tobacco companies," he continued in the Esquire interview. "Alcohol is a much worse problem than cigarettes."

Still, the free-wheeling marketeer wasn't ready to reinstate Prohibition because of Freddy, and that attitude extended to drugs. In the early 1990s, Trump reportedly talked about drug legalization, calling drug law enforcement "a joke" and saying "You have to legalize drugs to win that war. You have to take the profits away from these drug czars."

But Trump was singing a different tune on the campaign trail, especially in New Hampshire, which has been hit hard by the opioid wave. In a November 2015 interview with ABC News' Martha Raddatz, Trump backtracked.

"Well, I did not think about it," he confessed. "I said it's something that should be studied and maybe should continue to be studied. But it's not something I'd be willing to do right now. I think it's something that I've always said maybe it has to be looked at because we do such a poor job of policing. We don't want to build walls. We don't want to do anything. And if you're not going to want to do the policing, you're going to have to start thinking about other alternatives. But it's not something that I would want to do."

[image:3 align:left caption:true]That suggests that he thinks if we just enforce drug laws more vigorously, we could solve the problem. But it also suggests that he hasn't really been paying attention to the last 40 years of the war on drugs. Still, he has also said that marijuana legalization "should be a state issue, state by state," suggesting that he will not try to roll back pot legalization in the eight states that have now voted to free the weed.

And in an October 15 speech in New Hampshire, where he made his most coherent remarks about drug policy, he was mainly about building the wall on the Mexican border to stop the flow of heroin from Mexico. But in that speech, he at least sketched the outlines of response that included increased access to the overdose reversal drug naloxone, increased reliance on drug courts, and increased access to the silver bullet of drug addiction, "abuse-deterring drugs." But he didn't say anything about how much he would be willing to spend on treatment and recovery (Hillary Clinton rolled out a $10 billion plan), nor how he would pay for it.

As with many policy areas, Trump's positions on drug policy are murky, seemingly only half-developed, and full of potential contradictions. Will having a teetotaler with a dead alcoholic brother in the White House make for better drug policies or an administration more understanding of the travails of addiction? As with many things Trump, we shall have to wait for his actions. Nominating drug war hardliners like Sen. Jeff Sessions (R-AL) to head the Justice Department and giving Vice President-elect Mike Pence props for enacting mandatory minimum drug sentences aren't good omens, though.

Categories: Latest News

Global Commission on Drugs Calls for WorldWide Drug Decriminalization [FEATURE]

Mon, 11/21/2016 - 23:53

In a report released Monday, global leaders denounced harsh responses to drug use, such as the mass killing of drug users in the Philippines under President Rodrigo Duterte, and called for worldwide drug decriminalization.

[image:1 align:left caption:true]The report, Advancing Drug Policy Reform: A New Approach to Drug Decriminalization, is a product of the Global Commission on Drug Policy, a high-level panel that includes former UN Secretary-General Kofi Annan; former presidents of Brazil, Colombia, Mexico, and Switzerland; and British philanthropist Richard Branson, among others.

Since its inception in 2011, the Commission has consistently called for drug decriminalization, but this year's report goes a step further. Unlike existing decriminalization policies around the world, where drug users still face fines or administrative penalties, the report argues that no penalties at all should attach to simple drug possession.

"Only then," the report says, "can the societal destruction caused by drug prohibition be properly mitigated."

And the report breaks more new ground by calling for the decriminalization of other low-level players in the drug trade, including small dealers who sell to support their habits, drug mules, and people who grow drug crops. Many of those people, the report notes, engage in such activities out of "economic marginalization…a lack of other opportunities…or coercion," yet face severe sanctions ranging from the destruction of cash crops to imprisonment and even the death penalty.

Unlike people caught with drugs for personal use, however, the Commission envisions such low-level players being subjected to civil penalties, although not criminal ones.

"After years of denouncing the dramatic effects of prohibition and the criminalization of people that do no harm but use drugs on the society as a whole, it is time to highlight the benefits of well-designed and well-implemented people centered drug polices," said former Swiss President Ruth Dreifuss, Chair of the Commission. "These innovative policies cannot exist as long as we do not discuss, honestly, the major policy error made in the past, which is the criminalization of personal consumption or possession of illicit psychoactive substances in national laws."

"At the global, regional or local levels, drug policies are evolving," added C├ęsar Gaviria, former president of Columbia and Global Commission member. "However, in order to build solid and effective policies to mitigate the harms of the last 60 years of wrong policies, and to prepare for a better future where drugs are controlled more effectively, we need to implement the full and non-discretionary decriminalization of personal use and possession of drugs."

The new report from the Global Commission on Drug Policy issues the following recommendations

1. States must abolish the death penalty for all drug-related offenses.

2. States must end all penalties—both criminal and civil—for drug possession for personal use, and the cultivation of drugs for personal consumption.

3. States must implement alternatives to punishment for all low-level, non-violent actors in the drug trade.

4. UN member states must remove the penalization of drug possession as a treaty obligation under the international drug control system.

5. States must eventually explore regulatory models for all illicit drugs and acknowledge this to be the next logical step in drug policy reform following decriminalization.

[image:2 align:right caption:true]"People who use drugs have paid a huge toll to the current drug control system; they faced alone and without any legal protection the ravages of HIV/AIDS, hepatitis, as well as many non-communicable diseases," said Professor Michel Kazatchkine, former Executive Director of the Global Fund on AIDS, tuberculosis and malaria. "Now we have the scientific and medical tools to provide all the services they need, but we mostly lack the political leadership to implement an enabling legal environment. This starts by the complete decriminalization of drugs."

The Global Commission on Drug Policy was established in 2010 by political leaders, cultural figures, and globally influential personalities from the financial and business sectors. The Commission currently comprises 23 members, including nine former heads of states and a former Secretary General of the United Nations. The high-level group's mission is to promote evidence-based drug policy reforms at international, national and regional levels, with an emphasis on public health, social integration and security, and with strict regard for human rights.

Categories: Latest News

Marijuana Wins Big on Election Day, But Faces Uncertain Future Under Trump [FEATURE]

Wed, 11/09/2016 - 20:00

Donald Trump wasn't the only big winner on Tuesday. Marijuana law reform also had a stellar night, with medical marijuana winning in all four states it was on the ballot and marijuana legalization winning four out of five.

[image:1 align:left]Pot legalization won in California (Prop 64), Maine (Question 1), Massachusetts (Question 4), and Nevada (Question 2), losing only in Arizona (Prop 205), where a deep-pocketed opposition led by a hostile sitting governor managed to blunt the reform thrust. Medical marijuana won overwhelmingly in Florida (Amendment 2), the first state in the South to embrace full-blown medical marijuana, as well as in Arkansas (Question 6), Montana (I-182), and North Dakota (Measure 5).

This week's election doubles the number of legal marijuana states from four to eight and brings the number of full-fledged medical marijuana states to 28. It also means some 50 million people just got pot-legal, more than tripling the number of people living in states that have freed the weed.

 "This is one of the most significant days in the history of marijuana prohibition and this movement," said Rob Kampia, long-time head of the Marijuana Policy Project (MPP), which was behind the legalization initiatives in Arizona, Maine, Massachusetts, and Nevada and which also backed the California initiative. "When four states legalize it, it's a big deal, and California is an even bigger deal. The next time we'll see a day as important as yesterday is when a president signs a bill to end federal marijuana prohibition."

A major question is whether Donald Trump might be that president. During the campaign, he suggested that he would follow President Obama's lead and not interfere with state-level marijuana legalization and regulation (roughly the same position as Hillary Clinton). But his political alliances leave some reformers less than sanguine about a Trump administration.

[image:2 align:right]"Marijuana reform won big across America on Election Day - indeed it's safe to say that no other reform was approved by so many citizens on so many ballots this year," said Ethan Nadelmann, executive director of the Drug Policy Alliance, which was involved in the California campaign. "But the prospect of Donald Trump as our next president concerns me deeply. His most likely appointees to senior law enforcement positions - Rudy Giuliani and Chris Christie - are no friends of marijuana reform, nor is his vice president.

 "The momentum for ending marijuana prohibition took a great leap forward with the victories in California and elsewhere, but the federal government retains the power to hobble much of what we've accomplished," Nadelmann continued. "The progress we've made, and the values that underlie our struggle - freedom, compassion, reason and justice - will be very much at risk when Donald Trump enters the White House."

MPP's Kampia had a more optimistic take.

"The positions of Clinton and Trump were very similar," he said. "We have no reason to believe Trump would escalate the war on nonviolent marijuana users in states where it is legal. States will continue moving forward, and we will see a string of successes in the future, as well as being able to implement the laws passed yesterday."

That remains to be seen, as does the chance that a Republican Congress will move in a positive direction on marijuana. In a Wednesday tele-conference, marijuana reform stalwart Rep. Earl Blumenauer (D-OR), pointed to three areas where congressional action is needed: reforming the IRS's 280-E tax code provision that bars marijuana businesses from getting normal business tax breaks, reforming Treasury Department regulations that bar financial institutions from doing business with pot businesses, and removing barriers to research on marijuana's medical efficacy.

"I believe the next administration will follow the policy of the Obama administration," he said. "We had strong support for legalization in nine diverse states, with more support for these legalize, regulate, and tax policies than for either presidential candidate. The people have spoken, and that will make it easier for us in Congress to build bipartisan support for this legislation. There are now 28 states where there are state-legal businesses having to pay their taxes with shopping bags full of $20 bills. We have growing support in the House and Senate to stop this insanity," Blumenauer said.

[image:3 align:left]"I believe we will see action within the next two years to stop this discrimination against state-legal marijuana businesses," he prophesied. "Now that the playing field has expanded dramatically, including that overwhelming vote in Florida, which will become the second largest state marijuana market in the country, there is even more incentive. Some representatives are ambivalent or even opposed to marijuana legalization, but will serve their constituents."

But, as DPA's Nadelmann noted, even if Congress is favorably disposed to move in a positive direction on marijuana, the Trump executive branch is likely to feature staunch foes of marijuana law reform. Will advisors and possible appointees such as Chris Christie, Rudy Giuliani, and Mike Pence push Trump to try to undo the spreading marijuana legalization movement? And will Trump listen if they do? We will know the answer to these questions only in the fullness of time.

In the meantime, voters in initiative and referendum states and legislators in states without the initiative process can work to create more facts on the ground, more legalization states. National public opinion polls—and this week's elections—show that marijuana legalization is a winning issue. And the more states that legalize it, the more ridiculous, or as Obama put it this week, "untenable," federal marijuana prohibition becomes. Even a Trump victory, with all the frightening prospects that brings, may not be able to stop the marijuana juggernaut. 

Categories: Latest News

Using Medical Marijuana to Reduce Dependence on Opiates in an Aging, Aching Population [FEATURE]

Mon, 11/07/2016 - 21:38

Pain is a drag. And chronic pain is a never-ending drag. Unfortunately, as we grow older, we can expect to increasingly suffer its torments. Half of older adults who live on their own report suffering from chronic pain. For people in elderly care facilities, that figure jumps to somewhere around 80%.

[image:1 align:left caption:true]An aging population with its associated aches and pains is one reason opioid pain prescriptions have increased so dramatically this century. Opiates are a very popular pain management technique, despite the well-known problems with them, primarily addiction and lethality. They can ease your pain, but they can also kill you or get you strung out. And opiate users report other problems less severe, but still affecting quality of life, such as constipation and foggy-headedness.

In recent years, we have seen increasing evidence that one substance can reduce both pain and the reliance on opioids to treat it, and that its use can have a positive impact on fatal opioid overdoses. That substance is marijuana.

As the Johns Hopkins Bloomberg School of Public Health reported in 2014, "In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25% lower than in states where medical marijuana remains illegal."   

Now, new research findings from Care By Design, one of California's leading medical marijuana producers, add more evidence of the positive role marijuana can play in treating chronic pain and reducing dependence on opioid pain medications. The study surveyed 800 patients, mostly between 50 and 70, more than 80% of whom reported suffering from chronic pain, half of whom reported suffering from acute pain, and more than 40% of whom reported suffering from both.

These patients were in a world of hurt and had tried a number of pain management tools—opiates, medical marijuana, anti-inflammatory agents (NSAIDS), nerve blockers, exercise/physical therapy, and surgery—with respondents reporting trying an average of four of them. A quarter of patients reported having tried all six.  

The patients reported that marijuana was very effective for pain, with few negative side effects.  That was in striking distinction to opiates, which patients also said were effective for pain, but had a significant negative impact on quality of life for a significant number of them. In fact, the differences between the two substances in terms of quality of life were so dramatic they led to dramatic changes in patient behavior.

[image:2 align:right caption:true]"This survey brings some very important information to light," said Care By Design spokesman Nick Caston. "We see here in our patient data that cannabis is improving the quality of life of our patients—particularly elderly patients suffering from age-related pain—and that it does so without the dangerous side effects of other pain management modalities. 

"The study’s most striking finding was cannabis’ apparent impact on opiate reliance: Ninety-one percent of survey respondents reported that they decreased the amount of opiates they were taking or eliminated them altogether," Caston continued.

The study also found while marijuana, opiates, exercise/physical therapy, and NSAIDS all provided noticeable pain relief in more than half the patients, marijuana was the only pain management tool where there were no reports of worsening pain. And half of the patients using opiates reported that they had a negative impact on overall well-being, interfering with mood, energy, sleep, and functional abilities.

More than half of the patients reported using both marijuana and opiates to manage pain. But as noted above, nine out of 10 reduced or eliminated their opiate consumption after beginning to use marijuana. And nearly two-thirds (63%) said they were now off opiates altogether.

Over half of respondents reported that they had used both cannabis and opiates for pain management. Of great interest was the impact of cannabis therapy on opiate usage: Ninety-one percent of this subgroup reported that they used fewer or no opiates after beginning cannabis therapy. Sixty-three percent said that they went off opiates altogether.

"A tenet of healthcare in the United States is 'First, do no harm,'" the study concluded. "Patient reports of cannabis’ efficacy together with its low side effect profile suggest that it should be considered as a first-line treatment for pain and/or as an adjunct treatment to opiates rather than as a medication of last resort."

In other words, if we want to reduce the reliance on opioids, with all their negatives, for the management of pain in an aging population, we should be easing access to medical marijuana. With medical marijuana legal in 25 states, we're halfway there. 

Categories: Latest News

Clinton's and Trump's Drug Policies [FEATURE]

Wed, 11/02/2016 - 21:10

(This article was written prior to the election.)

One means of judging the competing presidential candidates is to examine their actual policy prescriptions for dealing with serious issues facing the country. When it comes to drug policy, the contrasts between Hillary Clinton and Donald Trump couldn't be more telling.

[image:1 align:right caption:true]The country is in the midst of what can fairly be called an opioid crisis, with the CDC reporting 78 Americans dying every day from heroin and prescription opioid overdoses. Both candidates have addressed the problem on the campaign trail, but, as is the case in so many other policy areas, one candidate has detailed proposals, while the other offers demagogic sloganeering.

Guess which is which.

Hillary Clinton has offered a detailed $10 billion plan to deal with what she called the "quiet epidemic" of opioid addiction. Donald Trump's plan consists largely of "build the wall."

That was the centerpiece of his October 15 speech in New Hampshire where he offered his clearest drug policy prescriptions yet (though it was overshadowed by his weird demand that Hillary Clinton undergo a drug test).  To be fair, since then, Trump has also called for expanding law enforcement and treatment programs, but he has offered no specifics or cost estimates.

And the centerpiece of his approach remains interdiction, which dovetails nicely with his nativist immigration positions.

[image:2 align:left caption:true]"A Trump administration will secure and defend our borders," he said in that speech. "A wall will not only keep out dangerous cartels and criminals, but it will also keep out the drugs and heroin poisoning our youth."

Trump did not address the failure of 40 years of ever-increasing border security and interdiction policies to stop the flow of drugs up until now, nor did he explain what would prevent a 50-foot wall from being met with a 51-foot ladder.

Trump's drug policy also takes aim at a favorite target of conservatives: so-called sanctuary cities, where local officials refuse to cooperate in harsh federal deportation policies.

"We are also going to put an end to sanctuary cities, which refuse to turn over illegal immigrant drug traffickers for deportation," he said. "We will dismantle the illegal immigrant cartels and violent gangs, and we will send them swiftly out of our country."

In contrast, Clinton's detailed proposal calls for increased federal spending for prevention, treatment and recovery, first responders, prescribers, and criminal justice reform. The Clinton plan would send $7.5 billion to the states over 10 years, matching every dollar they spend on such programs with four federal dollars. Another $2.5 billion would be designated for the federal Substance Abuse Prevention and Treatment Block Grant program.

[image:3 align:right caption:true]While Trump advocates increased border and law enforcement, including a return to now widely discredited mandatory minimum sentencing for drug offenders, Clinton does not include funding for drug enforcement and interdiction efforts in her proposal. Such funding would presumably come through normal appropriations channels.

Instead of a criminal justice crackdown, Clinton vows that her attorney general will issue guidance to the states urging them to emphasize treatment over incarceration for low-level drug offenders. She also supports alternatives to incarceration such as drug courts (as does Trump). But unlike Trump, Clinton makes no call for increased penalties for drug offenders.

Trump provides lip service to prevention, treatment and recovery, but his rhetorical emphasis illuminates his drug policy priorities: more walls, more law enforcement, more drug war prisoners.

There is one area of drug policy where both candidates are largely in agreement, and that is marijuana policy. Both Clinton and Trump have embraced medical marijuana, both say they are inclined to let the states experiment with legalization, but neither has called for marijuana legalization or the repeal of federal pot prohibition.

If Clinton's drug policies can be said to be a continuation of Obama's, Trump's drug policies are more similar to a return to Nixon's. 

(This article was prepared by StoptheDrugWar.org"s lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Categories: Latest News

Flailing Trump Pivots to Drug Policy, Demands Hillary Drug Test, Pivots Away Again [FEATURE]

Wed, 10/19/2016 - 21:40

This article was produced in collaboration with AlterNet and first appeared here.

Reeling from allegation after allegation of sexual misconduct, Republican presidential contender Donald Trump tried to go on the offensive on drug policy over the weekend, but in a manner typical of his campaign, he touched only briefly on the topic before flying off on new tangents, and he began his drug policy interlude with a bizarre attack on Hillary Clinton.

[image:1 align:left caption:true]At a speech at a Toyota dealership in Portsmouth, New Hampshire, Saturday, the GOP candidate claimed that Clinton was on performance-enhancing drugs before their last debate and suggested drug tests were in order.

"Why don't we do that?" he demanded, adding that Clinton was likely "getting pumped up" as the prepared for that debate.

"We should take a drug test prior cause I don't know what's going on with her. But at the beginning of last debate, she was all pumped up at the beginning and at the end it was like, oh take me down. She could barely reach her car," he claimed.

The claim didn't come out of nowhere. Trump was echoing an ad from two weeks ago from the pro-Trump super PAC Make America Number 1 that showed Clinton coughing and then stumbling to her van on the morning of September 11. The super PAC is bankrolled by Trump backer and big time conservative donor Robert Mercer, who dropped $2 million on the PAC in July.

The unfounded allegation of Clinton pre-debate drug use and the demand for a drug test grabbed media attention, but if Trump was attempting to turn a corner and shift the campaign's focus away from his peccadillos, his strange accusation against Clinton only served to raise more questions about his temperament and suitability for the nation's highest office.

[image:2 align:right caption:true]And it virtually smothered any discussion of actual drug policy proposals Trump made during the speech. While Trump has obliquely addressed the heroin and prescription opioid problem in the past, Saturday's speech was the first time he tried to put any flesh on his proposals for dealing with it.

If anyone were paying attention to the policy details amidst all the racket about the drug test challenge, they would have heard drug policy proposals rooted squarely in the failed drug war strategies of the last century.

Trump would, he said, block drugs from coming into the US by -- you guessed it -- building the wall on the Mexican border. He would also seek to tighten restrictions on the prescribing of opioids. And he would reinstitute mandatory minimum sentences for drug offenders.

"We have 5 percent of the world's population but use 80 percent of the prescription opioids," Trump said, eerily echoing former rival Jeb Bush, who used the same language while campaigning in the state earlier this year.

That statistic is aimed at showing that the US is over-prescribing narcotic pain killers, but according to the World Health Organization, the actuality is that in much of the rest of the world, they are underprescribing them. In fact, the WHO said that in more than 150 countries with 83 percent of the global population, there is virtually no access to prescription opioids for relief of pain.

And the under-treatment of chronic pain isn't just a problem in India or China or Africa. According to the National Institute of Health, more than 50 million Americans suffer significant chronic or severe pain. An opioid policy that focuses only on reducing prescriptions without addressing the need for access to pain killing opioids for actual pain is only half a policy.

When it comes to the border, Trump correctly asserts that Mexico is the source of most of the heroin in the US (it produces 45% itself and another 51% comes from Latin America, mostly Colombia and Guatemala, often through Mexico), but relies on a hyper-interdiction policy ("build the wall") to thwart it. Interdiction -- blocking the flow of drugs into the country -- has been a pillar of US drug policy for decades, but despite massive border build ups and the doubling of the number of Customs and Border Patrol agents in the past 15 years, the drugs still flow.

[image:3 align:left caption:true]Interdiction hasn't done the trick so far, and there is no indication that even a Trumpian wall would make a difference. The creativity of drug smugglers is legendary, and the economic incentives under drug prohibition are great. As the saying goes, "Build a 50-foot wall, and they'll bring a 51-foot ladder" (or a tunnel).

The third component of his drug policy is a Reaganesque "lock 'em up." In his New Hampshire speech, he saluted running mate Mike Pence for increasing mandatory minimums for drug offenders as governor of Indiana.

"We must make similar efforts a priority for the nation," Trump said.

That position flies in the face of a growing bipartisan consensus that the use of mandatory minimums for drug offenses is draconian, ineffective, and harms mainly minority populations. During the Obama administration, mandatory minimum sentences have been reduced with congressional assent, and Obama himself has granted commutations to hundreds of drug war prisoners serving those draconian sentences, with little dissent.

Trump's drug policy is but a sketch, but even its vague outlines reflect outdated approaches to the issue and a quickness to resort to cheap demagoguery on the issue. Still, while there is plenty of room for discussion of his approach, Trump has apparently already left the issue behind, barely mentioning it since Saturday as he tilts at other windmills.

(This article was prepared by StoptheDrugWar.org's lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

Categories: Latest News